Skip to main content
    C

    Cogent Biosciences Inc (COGT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $27.44
    -1.12 (-3.92%)

    Market Cap: $4.97B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cogent Biosciences Inc (COGT) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Cogent Biosciences (COGT) is expected to report earnings on Feb 15, 2027. In the quarter ended Sep 30, 2026, Cogent Biosciences reported EPS of -$0.59, below the -$0.57 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    35%(12/34)
    Avg Surprise
    -22.27%

    Upcoming Estimates

    Reports Feb 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.64
    Range-$0.72 - -$0.55
    13 analysts
    Revenue Consensus
    $5.55M
    RangeN/A
    13 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.53
    Range-$0.56 - -$0.51
    3 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.44-19.6%
    60d ago-$0.51-3.9%
    30d ago-$0.52-2.9%
    7d ago-$0.52-2.9%
    Current-$0.53
    Revenue Consensus
    $29.19M
    Range$7.20M - $41.00M
    5 analysts

    Next Report

    COGT has an expected report date of Feb 15, 2027.

    Earnings History

    Of the 34 quarters below that had an estimate, COGT beat 12 and missed 22. The widest gap in the table came in the quarter ended Sep 30, 2020, when EPS landed 628.57% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.59-$0.57-$0.64 - -$0.45-3.51%MissN/A80 up, 1 downNov 5, 2026N/A
    Jun 30, 2026-$0.52-$0.55-$0.66 - -$0.49+5.45%BeatN/A102 up, 4 downAug 10, 2026N/A
    Mar 31, 2026-$0.53-$0.50-$0.66 - -$0.46-5.66%MissN/A81 up, 3 downMay 5, 2026N/A
    Dec 31, 2025-$0.56-$0.51-$0.60 - -$0.41-9.80%MissN/A121 up, 0 downFeb 17, 2026N/A
    Sep 30, 2025-$0.50-$0.52-$0.59 - -$0.42+3.85%BeatN/A125 up, 3 downNov 7, 2025N/A
    Jun 30, 2025-$0.53-$0.58-$0.66 - -$0.38+8.62%BeatN/A111 up, 2 downAug 5, 2025N/A
    Mar 31, 2025-$0.52-$0.58-$0.65 - -$0.44+9.05%BeatN/A71 up, 0 downMay 6, 2025N/A
    Dec 31, 2024-$0.09-$0.58-$0.67 - -$0.45+84.48%BeatN/A94 up, 5 downFeb 25, 2025$4.29M
    Sep 30, 2024-$0.64-$0.57-$0.67 - -$0.44-12.28%MissN/A110 up, 0 downNov 12, 2024N/A
    Jun 30, 2024-$0.59-$0.55-$0.66 - -$0.33-7.27%MissN/A100 up, 0 downAug 6, 2024N/A
    Mar 31, 2024-$0.62-$0.51-$0.59 - -$0.40-21.57%MissN/A90 up, 0 downMay 7, 2024N/A
    Dec 31, 2023-$0.63-$0.56-$0.66 - -$0.37-12.50%MissN/A110 up, 0 downFeb 26, 2024$5.59M
    Sep 30, 2023-$0.64-$0.53-$0.60 - -$0.41-20.75%MissN/A90 up, 0 downNov 2, 2023N/A
    Jun 30, 2023-$0.59-$0.46-$0.64 - -$0.45-28.26%MissN/A91 up, 0 downAug 8, 2023N/A
    Mar 31, 2023-$0.57-$0.53-$0.67 - -$0.45-7.55%MissN/A80 up, 0 downMay 9, 2023N/A
    Dec 31, 2022-$0.56-$0.52-$0.58 - -$0.40-7.69%MissN/A70 up, 0 downMar 14, 2023N/A
    Sep 30, 2022-$0.50-$0.52-$0.58 - -$0.39+3.85%BeatN/A60 up, 0 downNov 14, 2022N/A
    Jun 30, 2022-$0.71-$0.68N/A-4.41%MissN/AN/A1 up, 0 downAug 9, 2022N/A
    Mar 31, 2022-$0.68-$0.49-$0.63 - -$0.33-38.78%MissN/A60 up, 0 downMay 10, 2022N/A
    Dec 31, 2021-$0.60-$0.46-$0.58 - -$0.31-30.43%MissN/A7N/AMar 15, 2022N/A
    Sep 30, 2021-$0.48-$0.38-$0.53 - -$0.27-26.32%MissN/A62 up, 0 downNov 10, 2021N/A
    Jun 30, 2021-$0.43-$0.35-$0.57 - -$0.18-22.86%MissN/A6N/AAug 16, 2021N/A
    Mar 31, 2021-$0.34-$0.22-$0.68 - -$0.17-54.55%MissN/A6N/AMay 12, 2021N/A
    Dec 31, 2020-$6.06-$0.51-$1.79 - -$0.15N/AN/A-2264.3%6N/AMar 16, 2021N/A
    Sep 30, 2020-$1.02-$0.14N/A-628.57%MissN/AN/AN/ANov 9, 2020$312000
    Jun 30, 2020-$0.96-$0.84N/A-14.29%MissN/AN/AN/AAug 11, 2020$528000
    Mar 31, 2020-$0.80-$1.23N/A+34.96%BeatN/AN/AN/AMay 11, 2020$7.03M
    Dec 31, 2019$0.28-$1.14N/A+124.56%BeatN/AN/AN/AMar 26, 2020$15.29M
    Sep 30, 2019-$1.56-$1.30N/A-20.00%MissN/AN/AN/ANov 12, 2019$1.02M
    Jun 30, 2019-$1.36-$1.60N/A+15.00%BeatN/AN/AN/AAug 12, 2019$3.14M
    Mar 31, 2019-$1.56-$1.33N/A-17.29%MissN/AN/AN/AMay 13, 2019$3.05M
    Dec 31, 2018-$1.16-$1.41N/A+17.73%BeatN/AN/AN/AMar 28, 2019$3.81M
    Sep 30, 2018-$1.36-$1.40N/A+2.86%BeatN/AN/AN/ANov 12, 2018$2.04M
    Jun 30, 2018-$1.24-$1.38N/A+10.14%BeatN/AN/AN/AAug 13, 2018$1.67M
    Mar 31, 2018-$0.66-$0.36N/A-83.33%MissN/AN/AN/AMay 14, 2018$2.22M
    Dec 31, 2017-$0.24N/AN/AN/AN/AN/AN/AN/AMar 29, 2018$2.12M
    Sep 30, 2017-$0.40N/AN/AN/AN/AN/AN/AN/ANov 3, 2017$2.33M
    Mar 31, 2017-$0.58N/AN/AN/AN/AN/AN/AN/AJun 29, 2017$1.83M
    Last 38 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.11, after -$1.94 the year before. It was -$1.22 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.11N/A
    Dec 31, 2024-$1.94N/A
    Dec 31, 2023-$2.43N/A
    Dec 31, 2022-$2.45N/A
    Dec 31, 2021-$1.85N/A
    Dec 31, 2020-$8.84N/A
    Dec 31, 2019-$4.20N/A
    Dec 31, 2018-$4.42N/A
    Dec 31, 2017-$1.22N/A

    Frequently Asked Questions About COGT

    When is Cogent Biosciences's next earnings date?

    Cogent Biosciences's next earnings report is expected for Feb 15, 2027.

    Did COGT beat earnings estimates last quarter?

    No. Cogent Biosciences reported EPS of -$0.59 for the quarter ended Sep 30, 2026, below the -$0.57 estimate by 3.51%.

    What EPS do analysts expect from COGT next quarter?

    The consensus EPS estimate for Cogent Biosciences for the quarter ending Dec 31, 2026 is -$0.64 from 13 analysts, with estimates from -$0.72 to -$0.55.

    How often does COGT beat earnings estimates?

    Cogent Biosciences beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +11.56%.